Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Hindocha, W. Lawn, T. Freeman, H. Curran (2017)
Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent usersPsychopharmacology, 234
Matt Anderson (2014)
European Monitoring Centre for Drugs and Drug Addiction
Brian Haig (2018)
Exploratory Data AnalysisMathematical Statistics with Resampling and R
Femke Buisman-Pijlman, S. Rigter, J. Hoek, H. Goldschmidt, R. Niesink (2005)
Strong increase in total delta‐THC in cannabis preparations sold in Dutch coffee shopsAddiction Biology, 10
M. Forti, C. Morgan, P. Dazzan, C. Pariante, V. Mondelli, T. Marques, R. Handley, S. Luzi, M. Russo, A. Paparelli, A. Butt, S. Stilo, B. Wiffen, J. Powell, R. Murray (2009)
High-potency cannabis and the risk of psychosisBritish Journal of Psychiatry, 195
M. Elsohly, Zlatko Mehmedic, S. Foster, C. Gon, James Church (2016)
Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United StatesBiological Psychiatry, 79
S. Chandra, M. Radwan, C. Majumdar, James Church, T. Freeman, M. Elsohly (2019)
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)European Archives of Psychiatry and Clinical Neuroscience, 269
C. Hunault, C. Hunault, Koen Böcker, Koen Böcker, R. Stellato, R. Stellato, J. Kenemans, I. Vries, I. Vries, J. Meulenbelt, J. Meulenbelt (2014)
Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trialPsychopharmacology, 231
Dayong Lee, M. Bergamaschi, G. Milman, Allan Barnes, R. Queiroz, R. Vandrey, M. Huestis (2015)
Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.Journal of analytical toxicology, 39 8
Cristina Casajuana, Hugo López-Pelayo, María Balcells, L. Miquel, Lídia Teixidó, J. Colom, A. Gual (2016)
Working on a Standard Joint Unit: A pilot test.Adicciones, 29 4
Tory Spindle, E. Cone, N. Schlienz, John Mitchell, G. Bigelow, R. Flegel, Eugene Hayes, R. Vandrey (2018)
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use CannabisJAMA Network Open, 1
C. Zeisser, K. Thompson, T. Stockwell, C. Duff, C. Chow, K. Vallance, Andrew Ivsins, W. Michelow, D. Marsh, Paul Lucas (2012)
A ‘standard joint’? The role of quantity in predicting cannabis-related problemsAddiction Research & Theory, 20
Cristina Kögel, M. Balcells-Oliveró, H. López-Pelayo, L. Miquel, Lídia Teixidó, J. Colom, D. Nutt, J. Rehm, A. Gual (2017)
The Standard Joint Unit.Drug and alcohol dependence, 176
T. Freeman, Teodora Groshkova, A. Cunningham, R. Sedefov, P. Griffiths, M. Lynskey (2019)
Increasing potency and price of cannabis in Europe, 2006–16Addiction (Abingdon, England), 114
R. Niesink, S. Rigter, M. Koeter, T. Brunt (2015)
Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.Addiction, 110 12
G. Ridgeway, B. Kilmer (2016)
Bayesian inference for the distribution of grams of marijuana in a joint.Drug and alcohol dependence, 165
UN Crime (2019)
World Drug Report 2019World Drug Report
Melissa Norberg, J. Mackenzie, J. Copeland (2012)
Quantifying cannabis use with the timeline followback approach: a psychometric evaluation.Drug and alcohol dependence, 121 3
(2015)
Evidencia cannabis tabaco. Informe 2015. Comité nacional Para la prevención del tabaquismo
Nicole Walden, M. Earleywine (2008)
How high: Quantity as a predictor of cannabis-related problemsHarm Reduction Journal, 5
(2014)
Informe resultados de analisis de marihuana 2014
Peggy Pol, N. Liebregts, T. Brunt, J. Amsterdam, R. Graaf, D. Korf, W. Brink, M. Laar (2014)
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.Addiction, 109 7
W. Swift, Alexander Wong, Kong Li, J. Arnold, I. McGregor (2013)
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid ProfilePLoS ONE, 8
Analysis, 2
Peggy Pol, N. Liebregts, R. Graaf, D. Korf, W. Brink, M. Laar (2013)
Validation of self-reported cannabis dose and potency: an ecological study.Addiction, 108 10
S. Chandra, M. Radwan, C. Majumdar, James Church, T. Freeman, M. Elsohly (2019)
Correction to: New trends in cannabis potency in USA and Europe during the last decade (2008–2017)European Archives of Psychiatry and Clinical Neuroscience, 269
Sergio León, A. Castel, J. Fiz, M. Albaladejo (2005)
farmacología clínica del cannbis, 20
H. Pelayo, Laia Montagut, Cristina Kögel, M. Olivero (2018)
Post-truth Cannabis use: back to evidence-based medicine.Adicciones, 30 4
Robin Murray, H. Quigley, D. Quattrone, Amir Englund, M. Forti (2016)
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosisWorld Psychiatry, 15
(2019)
European Drug Report 2019: Trends and Developments. Lisbon (Portugal)
(2009)
Recommended methods for the identification and analysis of cannabis and cannabis products
This study aims to assess the potency and dose of Δ-9-Tetrahidrocannabinol (THC) and Cannabidiol (CBD) in cannabis joints. This will enable better estimates of the degree of exposure in a user and contribute towards a better understanding of potential harmful effects.Design/methodology/approachAnalysis of intact joints confiscated by law enforcement on the street in the autonomous region of Castilla y León (Spain) during the years 2017–2019.FindingsThis study analysed THC, CBN and CBD in marijuana joints (N = 744). Joints contain cannabis and tobacco (N = 729), had a median net weight 0.69 g (IQR = 0.28); concentration THC median was 6.30%(IQR = 4.51) and THC median dose 42 mg (IQR = 32.75). A total of 35.5% mixed joints contained CBN – median percentage 0.61% (IQR = 0.51). CBD was detected 10.3% of mixed joints – median percentage 0.13% (IQR = 0.12) and median dose 1 mg (IQR = 0.92). CBD/THC ratio presented median value of 0.02 (IQR = 0.02). The samples analysed comprised pure cannabis joints (N = 15), with THC median 11.86% (IWR = 6.30) or median dose of 118 mg.Originality/valueThe study found high values for concentration and dose of THC and CBD in cannabis joints, warning of high exposures for the user and associated potential consequences. The results obtained contribute new perspectives on the definition of a standard cannabis unit.
Drugs and Alcohol Today – Emerald Publishing
Published: May 19, 2021
Keywords: Public health; Cannabis; 9-Tetrahydrocannabinol; Cannabidiol; Cannabis
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.